Johnson & Johnson Articles

J&J RECALLS DIABETES TEST STRIPS

15 November 1993

STUDY SAYS CLOZARIL USE SAVES MONEY

15 November 1993

WILL CHIROS FLOAT TO THE TOP?

15 November 1993

US 3rd QTR AFFECTED BY STRONG DOLLAR

1 November 1993

MARKET WARMS TO COUGH & COLD SEASON IN USA

1 November 1993

J&J MERCK AGREEMENT IN UK

25 October 1993

JANSSEN APPOINTMENT

25 October 1993

JOHNSON & JOHNSON RECEIVE MARKETING APPROVAL IN AUSTRALIA

25 October 1993

HOECHST-ROUSSEL TO FIGHT COGNEX PATENT

11 October 1993

CELLTECH TO GET L 30M IN ROCHE DEAL

27 September 1993

GROWTH FORECAST FOR FRANCE'S STAGNANT OTCS

13 September 1993

ORTHO'S RETIN-A TESTED FOR SUNBURNT SKIN

6 September 1993

JOHNSON & JOHNSON SHEDS JOBS

23 August 1993

NEW YORK STOCK COMMENT

23 August 1993

SELF MEDICATION TO PASS $27BILLION IN MAJOR MARKETS

23 August 1993

EC INVESTIGATE J&J/MERCK OTC VENTURE

16 August 1993

NICOTINE PATCH COs SUFFER DECLINE IN US SALES

2 August 1993

WARNER-LAMBERT OTC DEALS ON ZOVIRAX, ZANTAC

2 August 1993

DAIICHI ENTERING NEW PRODUCT PHASE

26 July 1993

PENDING APPLICATIONS IN US CONTINUE TO DWINDLE

19 July 1993

TAGAMET A STEP NEARER TO OTC APPROVAL

12 July 1993

DAIICHI AND HOECHST AGREEMENT

12 July 1993

MONITORING AIDS DIABETES CONTROL

5 July 1993

SANDOZ/SCRIPPS DEAL TO BE FOUGHT BY US GOVT

28 June 1993

COMPETITIVE DYNAMICS IN PHARMA INDUSTRY

28 June 1993

US DRUGMAKERS AND "THE BLACK HOLE"

21 June 1993

MYLAN'S TOLMETIN APPROVED IN USA

14 June 1993

JAPAN SEEING HEAVY PHARMA R&D INVESTMENT

7 June 1993

JANSSEN TO EXPAND IN CHINA

31 May 1993

EARNINGS GROWTH EXPANSION SEEN FOR UCB

31 May 1993

OTC GASTROINTESTINALS IN THE USA

24 May 1993

SB AND J&J TO COPROMOTE IN USA

24 May 1993

GENETICS AND AMGEN SETTLE DISPUTE

17 May 1993

US DRUGMAKERS GOING IN FOR MORE LOBBYING

17 May 1993

STRONG GROWTH BY US PHARMA COs IN 1st QTR

10 May 1993

US NIH INABILITY TO ENFORCE FAIR PRICING

3 May 1993

LARGE-SCALE US TB TRIAL PLANNED

26 April 1993

PRICE FLEXIBILITY AND THE DRUG INDUSTRY

12 April 1993

NEW YORK STOCK COMMENT

29 March 1993

MERCK & CO "MOST ADMIRED" US FIRM

29 March 1993

1st QTR WARNING FROM MMD

22 March 1993

US DRUG FIRMS' ANTITRUST MOVE

15 March 1993

PHARMACEUTICAL DESIGN: EPITOPE SELECTION

15 March 1993

JANSSEN TO PRESS ON WITH R 89439 DEV'T

8 March 1993

SCIOS NOVA HAS BROAD TECHNOLOGY BASE

8 March 1993

US FIRMS DISCUSS PRICES WITH HMO

22 February 1993

NEW YORK STOCK COMMENT

15 February 1993

US 4th QTR SHOWS NOT ALL COMPANIES STRONG

15 February 1993

NDMA APPOINTMENTS

18 January 1993

BIOCHEM PHARMA ITALIAN DEAL

18 January 1993

US OTC ANALGESICS - A 1992 RETROSPECTIVE

4 January 1993

JOHNSON & JOHNSON RECEIVES APPROVAL

21 December 1992

CENTOCOR TO DIVEST IMAGING PRODUCTS

21 December 1992

SANDOZ/SCRIPPS INST "LANDMARK" DEAL

14 December 1992

CANADA'S C-91: OPPOSERS HAVE THEIR SAY

14 December 1992

US CONGRESS REPORT ON OFF-LABEL PROMOTION

7 December 1992

FUJISAWA'S PROMISING R&D PIPELINE

9 November 1992

US RESULTS 3RD QTR

2 November 1992

J&J SETTLES IN 3M DISPUTE

12 October 1992

US/EURO PHARMA INROADS INTO CIS

5 October 1992

BRAZIL PHARMA MARKET DREAM OR NIGHTMARE?

7 September 1992

JOHNSON & JOHNSON CHAIRMAN

3 August 1992

GOOD GROWTH FOR US COMPANIESCONTINUES FOR US COs

3 August 1992

US PHARMA INDEX LAUNCHED

29 June 1992

THE CHANGING MARKET FOR HERBAL MEDICINES

29 June 1992

J&J'S LEVAMISOLE "OVERPRICED"

1 June 1992

ICI sell Savlon rights

1 June 1992

Rx-to-OTC switch - key to OTC market in USA By Mick Maroney, manager, North

1 June 1992

H PYLORI TREATMENT: A ROLE FOR OMEPRAZOLE?

25 May 1992

US DRUG FIRMS' PUERTO RICO TAX CREDITS

25 May 1992

EUROPEAN MARKET FOR SELF-MEDICATION

18 May 1992

McNEIL - ANTHONY TEMPLE

11 May 1992

GOOD 1st QTRs for ALZA, IMMUNEX AND MYLAN

4 May 1992

NEW J&J PREGNANCY TEST FOR UK

27 April 1992

ROBERTS TO MARKET J&J'S SUPPRELIN

27 April 1992

J&J IN STOCK REPURCHASE

20 April 1992

US MARKET FOR FLU TREATMENTS

17 February 1992

US OTC DRUGMAKERS A TAKEOVER TARGET

17 February 1992

RECORD 4TH QTR FROM US DRUG COMPANIES

10 February 1992

B-M SQUIBB GIVES HEART DRUGS FREE TO POOR

3 February 1992

BRAZILIAN DRUG PRICE INCREASES

3 February 1992

J&J CONTRACEPTIVE VACCINE PLANS

27 January 1992

FDA GENERIC MONOGRAPH AND PROMO PLANS

20 January 1992

US FDA BEATS 1990 DRUG APPROVALS IN 1991

13 January 1992

AKZO AFTER 15% of US PILL MARKET

6 January 1992

ANALGESICS IN THE USA -- AN OPEN DOOR FOR P&G?

6 January 1992

WORLD OTC MARKETS STUDIED

6 January 1992

Teva's generic Risperdal cleared in USA